BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19648147)

  • 1. Atraumatic osteonecrosis after estrogen replacement therapy associated with low protein S level in a patient with Turner syndrome.
    Ureten K; Ozturk MA; Bostanci A; Ceneli O; Ozbek M; Haznedaroglu IC
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):599-601. PubMed ID: 19648147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement in a protein S deficient patient leads to diarrhea, hyperglucagonemia, and osteonecrosis.
    Glueck CJ; Phillips HG; Cameron D; Wang P
    JOP; 2001 Sep; 2(5):323-9. PubMed ID: 11877543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and natural history of osteonecrosis.
    Assouline-Dayan Y; Chang C; Greenspan A; Shoenfeld Y; Gershwin ME
    Semin Arthritis Rheum; 2002 Oct; 32(2):94-124. PubMed ID: 12430099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement and the risk of breast cancer in Turner's syndrome.
    Bösze P; Tóth A; Török M
    N Engl J Med; 2006 Dec; 355(24):2599-600. PubMed ID: 17167149
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protein S deficiency and thrombophilia: presentation of a clinical case and review of the literature].
    Iannello S; Prestipino M; Volpicelli G; Campione R; Belfiore F
    Ann Ital Med Int; 1994; 9(3):153-9. PubMed ID: 7946892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual cause of recurrent chorea.
    Caviness JN; Muenter MD
    Mov Disord; 1991; 6(4):355-7. PubMed ID: 1661846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and thrombosis.
    Schrogie JJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):526. PubMed ID: 18323862
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thrombosis and conjugated equine estrogen in women without a uterus.
    Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
    Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial adenocarcinoma without prior hormone replacement in a diabetic patient with gonadal dysgenesis.
    Kratzert-Adams K; Adelson MD; Badawy SZ; Stein CK; Gordon L
    Obstet Gynecol; 1992 May; 79(5 ( Pt 2)):849-53. PubMed ID: 1565385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are hormone substitution and vitamins dangerous for elderly women with heart diseases?].
    Schenck-Gustafsson K
    Lakartidningen; 2003 May; 100(20):1784-6. PubMed ID: 12806858
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimentally gained insight - based proposal apropos the treatment of osteonecrosis of the femoral head.
    Boss JH; Misselevich I; Bejar J; Norman D; Zinman C; Reis DN
    Med Hypotheses; 2004; 62(6):958-65. PubMed ID: 15142657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with estrogen].
    Ingelman-Sundberg A
    Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration.
    Alves ST; Gallichio CT; Guimarães MM
    Gynecol Endocrinol; 2006 Oct; 22(10):590-4. PubMed ID: 17135039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.